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Abstract
Vaccination of chickens has become routine practice in Asian countries in which H5N1 highly pathogenic avian
influenza (HPAI) is endemically present. This mainly applies to layer and breeder flocks, but broilers are usually left
unvaccinated. Here we investigate whether vaccination is able to reduce HPAI H5N1 virus transmission among
broiler chickens. Four sets of experiments were carried out, each consisting of 22 replicate trials containing a pair
of birds. Experiments 1-3 were carried out with four-week-old birds that were unvaccinated, and vaccinated at day
1 or at day 10 of age. Experiment 4 was carried out with unvaccinated day-old broiler chicks. One chicken in each
trial was inoculated with H5N1 HPAI virus. One chicken in each trial was inoculated with virus. The course of the
infection chain was monitored by serological analysis, and by virus isolation performed on tracheal and cloacal
swabs. The analyses were based on a stochastic SEIR model using a Bayesian inferential framework. When
inoculation was carried out at the 28th day of life, transmission was efficient in unvaccinated birds, and in birds
vaccinated at first or tenth day of life. In these experiments estimates of the latent period (~1.0 day), infectious
period (~3.3 days), and transmission rate parameter (~1.4 per day) were similar, as were estimates of the
reproduction number (~4) and generation interval (~1.4 day). Transmission was significantly less efficient in
unvaccinated chickens when inoculation was carried out on the first day of life. These results show that vaccination
of broiler chickens does not reduce transmission, and suggest that this may be due to the interference of maternal
immunity.
Introduction
Infection of poultry with highly pathogenic avian influ-
enza (HPAI) virus strains invariably results in high mor-
tality rates and substantial economic losses [1-6]. It is
now almost 15 years ago that the first outbreaks of
highly pathogenic H5N1 viruses were reported in South
East Asia. Since then, the disease has become endemic
in some countries [7]. Outbreaks caused by infection
with H5N1 viruses resulted in the death of millions of
birds either from the disease, or by culling. In addition,
hundreds of human infections, including 306 fatal ones,
have been reported [8].
Upon detection of an outbreak in commercial poultry,
a set of control measures, including culling of infected
flocks, is implemented [2,9,10]. Eradication of the H5N1
virus from poultry has been successful in some coun-
tries, but in Egypt and Indonesia the virus seems to
have become endemic [7,11-13]. In some of these ende-
mically infected countries vaccination of breeders and
layer hens has become a widely used containment strat-
egy that has met with variable success [14-17]. In Indo-
nesia, vaccination is widely applied, but it is unclear
what the epidemiological situation is, as no official data
are available for commercial flocks [18]. Despite vacci-
nation, it is believed that outbreaks in commercial flocks
continue to occur. An indication for this is that on sev-
eral poultry collecting facility houses in Jakarta, where
spent layers and broilers were collected shortly before
slaughtering, H5 virus was isolated [8,19]. Another
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indication is the observation of an H5N1 outbreak in a
vaccinated commercial layer flock [20].
The situation has not improved in Indonesia since the
incursion of the virus in 2003 [7,21], and additional con-
trol options are urgently needed. Large-scale culling does
not seem an option, and, therefore the vaccination strat-
egy in endemically infected countries needs improve-
ment. A large part of the poultry industry in Indonesia
consists of broiler flocks, which are generally not vacci-
nated. The main reasons for the non-vaccination strategy
are the costs of vaccination, and the assumed ineffective-
ness of vaccination of broilers because of the interference
of maternally derived antibodies (MDA) with a vaccine-
induced immune response [17].
To be able to make an informed decision on whether
or not vaccination of broilers is useful in the control of
HPAI H5N1, and to investigate whether broilers were
able to transmit the infection at all, we investigated the
effect of vaccination on virus transmission. Focus was
on key epidemiological parameters such as the transmis-
sion rate parameter, the infectious period, the genera-
tion interval, and the reproduction number [22-24].
Estimation of these parameters in the field is possible,
but difficult even in endemically infected areas [20].
Experimental transmission studies offer the opportunity
to quantify these parameters under well-controlled con-
ditions [4,25]. Here we present the results of four sets of
experiments with HPAI H5N1 virus strain A/Chicken/
Legok/2003 in broiler chickens, to estimate epidemiolo-
gical parameters, and to determine the effect of a single
vaccination on transmission and clinical signs.
Materials and methods
Experiments were carried out in the high containment
unit at PT. Medion, Bandung, Indonesia. Four experi-
ments were done each with 22 replicates. Each replicate
consisted of one pair of broilers. Experiment 1 was car-
ried out with unvaccinated birds, experiment 2 with
birds vaccinated at day 1 of age, and experiment 3 with
birds vaccinated at day 10. Experiment 4 consisted of
progeny obtained from the same flock, but birds were
day-old at time of challenge (see below).
Animals and housing
Approximately 200 18-day-old embryonated eggs were
purchased from a commercial breeder farm. The bree-
ders were vaccinated several times against H5N1 with
Medivac® (PT Medion, Bandung, Indonesia), containing
H5N1 virus strain A/chicken/Legok/2003. At time of
purchase of the eggs, no clinical signs of AI in the bree-
ders were reported, indicating the absence of HPAI
H5N1 virus at that time.
After hatching at the facilities, day-old chicks were
housed in one experimental unit. They were fed with a
commercial ration, and had tap water ad libitum. Four
groups were formed each consisting of 44 birds for
each experiment one. Three groups (experiments 1-3)
were of the same age at purchase and challenge and
were used to determine the efficacy of vaccination. A
fourth group (experiment 4) consisted of day-old
chicks (DOC), and were challenged to determine
whether virus could be transmitted amongst DOC.
Challenge was done when birds in experiments 1-3
were 28 days old.
One week before challenge birds from experiments 1-
3 were moved to the experimental units. Two rooms
were available, each with two rows with cages on three
levels. Birds in experiments 2 and 3 were housed
together in Unit 1 and birds in experiment 1 were
housed together with those in experiment 4 in Unit 2:
each experimental group at opposite sides of the corri-
dor in each house. In each cage one pair of birds from
the same experiment was housed. The cages between
each experimental pair were empty. Sentinel birds were
placed in empty cages in the middle level below each
pair in the upper level. Sentinels were SPF layers, from
the SPF unit of PT Medion, and were not older than
the experimental birds. Sentinels were used to monitor
between-cage virus transmission. The experiments lasted
four weeks after inoculation, when the surviving birds in
experiments 1-3 were 56 days old.
Vaccine
An inactivated oil-emulsion vaccine was used, which
contained the H5N1 strain A/Chicken/Legok/2003
(Medivac®, PT Medion, Bandung, Indonesia) [26]. The
vaccine was administrated intramuscularly in one leg
using 0.5 mL containing 256 HAU per dose per bird.
Chickens in experiments 1 and DOC in experiment 4
remained unvaccinated; chickens in experiment 2 were
vaccinated at one day of age; the birds in experiment 3
were vaccinated at 10 days of age.
Inoculation
The HPAI virus strain H5N1 A/Chicken/Legok/2003
was used for challenge. The strain was provided by PT.
Medion Bandung Indonesia. The virus has been used
in other transmission experiments, and was able to
induce clinical signs and transmission [26,27]. At day
of challenge, when the birds in experiments 1-3 were
28 days old and in the DOC experiment (4) were 1
day old, one bird per pair was inoculated intranasally
and intratracheally with 0.2 mL inoculum containing
106/mL median egg infectious dose (EID50) [26]. Before
inoculation each bird that had to be inoculated was
put in the empty cage near its pen mate. Eight hours
after inoculation, they were placed back in their origi-
nal cage.
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Transmission experiments
Throughout, we refer to each experimental pair of
chickens as a trial. Each experiment consisted of 22
replicate trials, and in each trial one inoculated bird (I)
was placed in a cage with an uninfected contact bird
(C). Both birds had received the same treatment, and
were of the same age.
Transmission of virus was monitored by taking daily
swab samples from the trachea and cloaca from all birds
for 10 days. From birds that survived this sampling per-
iod, additional samples were taken at day 14 after chal-
lenge. The samples were stored at -70 °C until further
testing. Serum blood samples were taken from surplus
birds at day of hatch to determine the level of mater-
nally derived antibodies. From the experimental birds,
serum blood samples were taken two days before chal-
lenge and four weeks after challenge, at the end of the
experiment. Sera were stored at -20°C until further test-
ing. Clinical signs were recorded during four weeks after
challenge.
The treatment is referred to as: unvaccinated (experi-
ment 1), d1 vaccinated (experiment 2), d10 vaccinated
(experiment 3) and DOC (experiment 4). Figure 1 gives
an overview of the experimental data from days 0 to 10
after challenge. Additional samples were taken from
infectious birds that were still present at day 10 of the
experiment (not shown). The complete dataset is avail-
able on request from the corresponding author. All
experiments were carried out in accordance to article 80
on “Research in Animal Health” of the Indonesian “Law
on Livestock and Animal Health UU/18/2009”.
Tests
The presence of AI virus in swabs was determined by
virus isolation according to standard procedure
described by OIE [28]. Briefly, three SPF embryonated
chicken eggs, incubated for nine days, were inoculated
with 0.2 mL swab medium per egg. After 72 h, or when
the embryo had died before that time, the allantoic fluid
was harvested. A haemagglutination assay (HA) was per-
formed following standard procedure. When at least one
of the eggs was positive in the HA, the swab was con-
sidered to be positive. The test results were recorded as
positive for AI virus or negative [26]. A bird was consid-
ered infected if at least one sample (either tracheal or
cloacal) tested positive at least once.
Serum samples were tested in a haemagglutination
inhibition (HI) test according to standard procedures
[28]. It is generally assumed that HI titers ≥ 32 are pro-
tective against disease, i.e. clinical signs [29]. Tests were
carried out in duplo using 4 HAU of the strain A/
chicken/Legok/2003(H5N1). Two-fold dilutions of the
serum samples were made, and titers were expressed as
the serum dilution that caused complete inhibition of
agglutination [28].
Quantification of transmission
A Bayesian inferential framework based on a stochastic
SEIR (susceptible-exposed-infected and infectious-
removed) epidemic model was used to obtain quantita-
tive estimates of the parameters of interest [26,30-32].
The methods of analysis have been described in detail
earlier [26]. Here we give a concise overview.
The main interest is in the transmission rate para-
meter, and parameters of the latent and infectious per-
iod distributions. Together, these parameters determine
the basic reproduction number and the generation inter-
val [26]. We parameterize the latent and infectious peri-
ods using gamma distributions, and assume
uninformative uniform prior distributions (U(0.0001-
100)) for all parameters. To be precise, we characterize
gamma distributions of the latent and infectious periods
by their mean and variance (and not the shape and scale
parameters), and assume uniform prior distributions for
the mean and variance (and not the shape and scale
parameters).
In the following b denotes the transmission rate para-
meter, gE and δE the parameters determining the latent
period probability distribution, and gI and δI the para-
meters of the infectious period probability distribution.
Specifically, E[TE] = gE and, Var[TE] = δE, and E[TI] = gI
and Var[TI] = δI represent the means and variances of
these distributions. The corresponding probability densi-
ties are denoted by fE (x) and fI (x).
Further, ek ik, and rk are N-dimensional vectors which
contain the time points of the S®E, E®I, and I®R
transitions for inoculated (k = 1) and contact (k = 2)
birds in the N trials. Hence, we have e1 = (0,...,0)
T by
definition, and all other transition times are unknown.
The unknown transitions are imputed. We adopt the
convention that e2j denotes the exact time at which the
contact bird in experiment j is infected, that i1j denotes
the exact time that the inoculated bird in experiment j
became infectious, etc.
As in [26], the contribution of trial j to the likelihood
is given by
L(j) =
{
λ(j)
(
e2j
)
S(j)
(
e2j
)
fE
(
i1j
)
fI
(
r1j − i1j
)
fE
(
i2j − e2j
)
fI
(
r2j − i2j
)
if the contact birdwas infected
S(j)
(
r1j
)
fE
(
i1j
)
fI
(
r1j − i1j
)
if the contact birdwasnot infected. (1)
In the above equation l(j)(t) and S(j)(t) denote the
infection hazard in trial j at time t and the probability
that the contact bird in trial j remains uninfected up to
time t, respectively. If we let [...] denote the indicator
function, the infection hazard is given by
λ(j) (t) =
β
2
[
max
(
tadd, i1j
) ≤ t < r1j] , (2)
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Figure 1 Overview of the transmission studies. Shown are for each of the four experiments the experimental data of the 22 replicate trials.
The top and bottom rows of each trial refer to the experimentally infected chicken and contact chicken, respectively. Blue squares denote
chickens that tested negative, red squares represent chickens that tested positive, and black squares denote chickens that died or recovered
after infection.
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where the parameter tadd represents the delay between
the moment of inoculation and the moment that the
inoculated birds were placed back in their cages. Hence,
the function max(tadd,i1j) marks the beginning of the at-
risk period for the contact bird. In all trials and experi-
ments, the delay is 8 h, i.e. tadd = 0.33 (day). The prob-
ability that the contact bird in trial j remains uninfected
up to time t can be expressed in terms of the infection
hazard as follows
S (j)(t) = e
−
t∫
0
λ(j)(t′)dt′
.
(3)
With the above preparation at hand, the likelihood
function is given by the product of the contributions of
the individual trials given in equation 1. The above
equations are furthermore readily generalized to include
differences in the epidemiological parameters of inocu-
lated versus contact birds [26].
The epidemiological parameters and unobserved epi-
demiological transitions (i.e. S®E, E®I, I®R) were all
updated by a random-walk Metropolis algorithm. We
used Normal proposal distributions with the current
value as mean. After running a number of analyses to
explore the posterior distribution and optimize the pro-
posal distributions, we used standard deviations of 0.02
for the epidemiological transitions, and 0.02-0.5 for the
epidemiological parameters. The epidemiological para-
meters and unobserved transitions were updated in
blocks, in the order (1) timing of inoculated chickens
becoming infectious, (2) timing of removal of inoculated
chickens, (3) timing of infection of contact chickens, (4)
timing of contact chickens becoming infectious, (5) tim-
ing of removal of contact chickens, and (6) updating of
the epidemiological parameters [26]. Chains were run
for 350 000 cycles, of which the first 100 000 cycles
were discarded as burn-in. Thinning was applied by tak-
ing output from each twentieth cycle, yielding a sample
of 12 500.
Below we report not only the basic epidemiological
parameters (transmissibility, duration of the latent and
infectious periods), but also the generation interval and
basic reproduction number. The generation interval is
defined as the moment of infection of the contact bird
relative to the moment of infection of the inoculated
bird (i.e. it is given by e2j in trial j if the contact bird
was infected), while the basic reproduction number is
defined as the product of the transmission rate para-
meter (unit: day-1) and infectious period (unit: day).
Each of the Experiments 1-4 was analysed separately,
assuming a common distribution of the latent period of
inoculated and contact birds. Based on the results of
the separate experiments, and given the observation
that there may be differences between inoculated and
contact birds, possibly due to differences in the
inoculum size we also analysed the combined data of
Experiments 1-3 while relaxing this assumption. Specifi-
cally, we allowed the mean of the latent period to differ
between inoculated and contact birds, while assuming a
fixed common variance (0.001) of the latent periods
[26]. Furthermore, the data of Experiments 1-3 were
used to explore, by means of logistic regression,
whether the probability of infection could be dependent
on the immune status (i.e. HI titer) of the birds just
prior to the experiments.
Results
Experiment 1 (no vaccination, challenge at day 28)
All inoculated chickens shed virus for 1-7 days (inter-
quartile range: 2-5 days), and all inoculated chickens
died 2-8 days post challenge (interquartile range: 3-6
days post challenge) (Table 1, Figure 1). Likewise, all
but two of the contact chickens shed virus for 2 to
more than 8 days. All virus-positive inoculated chickens
showed clinical signs of highly pathogenic avian influ-
enza (data not shown) and died, and 16 of 22 contact
chickens died during the course of the experiments. At
challenge none of the birds had a HI titer greater than
or equal to 32, and only 1 of the surviving contact
chickens had developed a significant HI titer (≥ 32) at
the end of the experiment. The average HI titers are
represented in Table 1.
The estimated transmission rate parameter (i.e. the
median of the posterior distribution of the transmission
rate parameter) is 1.6 per day (95%CrI: 0.97-2.4) (Table
2). This implies that the estimated per day probability of
infection of an uninfected contact chicken by an
infected inoculated chicken is 1 - exp( - 1.6) = 0.80. The
estimated mean of the infectious period (i.e. the median
of the posterior distribution of the parameter determin-
ing the mean of the infectious period) is 3.2 days (95%
CrI: 2.5-4.3), while the estimated mean of the latent per-
iod is 0.88 days (95%CrI: 0.70-0.94) (Table 2). Based on
these estimates, the basic reproduction number and the
generation interval are 5.1 (95%CrI: 3.0-8.4) and 1.5
days (95%CrI: 1.3-1.7), respectively. Figure 2 gives a gra-
phical representation of the posterior distribution of the
mean versus variance of the latent period, and of the
infectious period and the mean infectious period versus
the transmission rate parameter.
Experiment 2 (vaccination at day 1, challenge at day 28)
All inoculated chickens shed virus, and 16 of 22 inocu-
lated chickens died before the end of the experiment.
Seventeen contact chickens shed virus, and 14 of 22
contact chickens died during the course of the experi-
ments. At challenge none of the birds had a HI titer
greater than or equal to 32; 4 of the surviving inoculated
and none of the surviving contact chickens developed a
Poetri et al. Veterinary Research 2011, 42:74
http://www.veterinaryresearch.org/content/42/1/74
Page 5 of 12
significant HI titer (≥ 32) at the end of the experiment.
The average HI titers are represented in Table 1.
The basic parameters of interest are very close to
those of experiment 1 (no vaccination). Specifically, the
estimated transmission parameter is 1.5 per day (95%
CrI: 0.87-2.3), the mean of the latent period is 0.86 days
(95%CrI: 0.69-0.96), and the mean of the infectious per-
iod is 3.7 days (95%CrI: 2.8-5.1) (Table 2). The basic
reproduction number and generation interval are also
quite close to the estimates in experiment 1, viz. 5.5
(95%CrI: 3.1-9.3) for the reproduction number, and 1.4
days (95%CrI: 1.2-1.5) for the generation interval (Table
2). Figure 3 shows that although there is a striking over-
all agreement with the results of experiment 1 (Figure
2), there is also some evidence of greater variability in
experiment 2 than in experiment 1, especially with
respect to the variance of the latent and infectious
periods.
Experiment 3 (vaccination at day 10, challenge at day 28)
Eighteen inoculated chickens shed virus, and 13 died of
AI (Table 2 Figure 3). Likewise, 15 contact chickens shed
virus and 15 of 22 contact chickens survived, including
the 7 that did not shed detectable levels of virus. At chal-
lenge none of the birds had a HI titer greater than or
equal to 32; 5 of the surviving inoculated and 8 of the
contact chickens developed a significant HI titer (≥ 32) at
the end of the experiment. The average HI titers are
represented in Table 1. Three contact chickens and the
inoculated one that did not develop HI > 32 did not shed
virus.
The results of the analysis of experiment 3 (vaccination
on the tenth day of life) are also similar to those of
experiments 1 (no vaccination) and 2 (vaccination at the
first day of life) (Figure 4). Here, estimates of the key
parameters are 1.3 per day (95%CrI: 0.69-2.1) for the
transmission rate parameter, 0.89 days (95%CrI: 0.56-1.1)
Table 1 Overview of HI titers at challenge, virus isolation data, clinical symptoms, and mortality rates
Number of birds
Mean HI titer (absolute (sd)) with HI titer ≥
2^5
at challenge
shedding virusa with clincial
symptoms
that died
Exp. Treatment at challenge
(2log)
at endd
(2log)
Ib Cb I C I C I C
1 no vaccination
challenge at d28 of age
1.6 (1.0) 206 (457) 0 0 22 19 22 22 22 16
2 vaccination at d1
challenge at d28 of age
1.7 (1.3) 166 (381) 0 0 22 18 19 16 16 15
3 vaccination at d10
challenge at d28 of age
1.8 (0.9) 251 (357) 0 0 18 15 16 10 13 7
4 no vaccination
challenge at day 1 of age
4.9 (1.2)c 1.0 (0.4)f Ndc nd 16 6 19 19 13 1
a total numbers in each group were 22 inoculated chickens and 22 contact-exposed chickens.
b I: inoculated chickens; C: contact-exposed chickens.
c not determined.
d only from surviving and infected birds.
e from surplus birds.
f one bird had a titer of 1024, which is omitted from this average.
Table 2 Overview of the statistical analyses
Exp. Treatment Transmission parameter
(day-1)(95%CrI)
Latent period
(day)(95%CrI)
Infectious period
(day)(95%CrI)
Reproduction number
(95%CrI)
Generation interval
(day)(95%CrI)
1 no vaccination
challenge at day 28
1.6 (0.97-2.4) 0.88 (0.70-0.94) 3.2 (2.5-4.3) 5.1 (3.0-8.4) 1.5 (1.3-1.7)
2 vaccination at day 1
challenge at day 28
1.5 (0.87-2.3) 0.86 (0.69-0.96) 3.7 (2.8-5.1) 5.5 (3.1-9.3) 1.4 (1.2-1.5)
3 vaccination at day 10
challenge at day 28
1.3 (0.69-2.1) 0.89 (0.56-1.1) 3.5 (2.5-5.2) 4.4 (2.3-8.3) 1.4 (1.2-1.5)
4 no vaccination
challenge at day 1
0.38 (0.17-0.72) 3.3 (2.4-4.1) 2.8 (2.1-3.7) 1.0 (0.45-2.1) 1.1 (0.77-1.3)
1-3 challenge at day 28 1.4 (1.1-1.9) i: 0.93 (0.88-0.96)
c: 0.96 (0.85-1.1)
3.3 (2.7-3.9) 4.6 (3.3-6.4) 1.4 (1.3-1.5)
Parameter estimates are given as posterior medians. Equal-tailed 95% credible intervals are shown between brackets. Estimates of the latent period in the
combined analysis of Experiments 1-3 refer to the inoculated (i) and contact (c) birds.
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Figure 2 Overview of the analyses of Experiment 1
(no vaccination, challenge at day 28). Shown are samples from
the marginal posterior density of the mean versus variance of the
latent period (A), the mean versus variance of the infectious period
(B), and the mean infectious period versus transmission rate
parameter (C).
Figure 3 Overview of the analyses of Experiment 2
(vaccination at day 1, challenge at day 28). See Figure 1 for
details.
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for the mean of the latent period, and 3.5 days (95%
CrI: 2.5-5.2) for the mean of the infectious period
(Table 2). The reproduction number and generation
interval are estimated at 4.4 (95%CrI: 2.3-8.3) and 1.4
days (95%CrI: 1.2-1.5), respectively. Figure 4 shows
that, in contrast with experiments 1 and 2, the var-
iance of the infectious period cannot be estimated with
high precision anymore, indicating that the experimen-
tal data contain little information on the variance of
the infectious period (Figure 4).
Experiment 4 (no vaccination, challenge at day 1)
In this experiment, 16 of 22 inoculated birds shed virus,
and 13 inoculated birds died (Table 1, Figure 5). Six of the
contact birds shed virus, and one died during the course
of the experiments. The birds used in the experiment were
very young, and could not be tested for the presence of
MDA before the experiment. Therefore, eighteen day-old
chickens that were not used in the experiments were bled,
and tested for the presence of MDA, and 13 of 18 had HI
titers ≥32, and had an average HI titer of 4.9.
The analyses of the experiment show substantial dif-
ferences in the parameter estimates when compared
with those resulting from the analyses of experiments 1-
3 (challenge at four weeks of age). The median of the
posterior of the transmission rate parameter is 0.38 per
day (95%CrI: 0.17-0.72), and the medians of the poster-
ior distribution of the mean of the latent and infectious
periods are 3.3 days (95%CrI: 2.4-4.1) and 2.8 days (95%
CrI: 2.1-3.7), respectively (Table 2). The estimates (i.e.
the medians of the posterior distribution) of the repro-
duction number and generation interval are 1.0 (95%
CrI: 0.45-2.1) and 1.1 days (95%CrI: 0.77-1.3), respec-
tively.The data contain little information on the variance
of the latent period (Figure 5).
Combined analysis (vaccination at day 28)
The above analyses indicate that vaccination had no
measurable effect on the transmission dynamics when
birds were infected and challenged at day 28 (Experi-
ments 1-3; Table 2). We therefore combined and reana-
lysed the data of these experiments to investigate
whether there were differences between inoculated and
contact birds in the latent period, and to explore the
relation between the HI titer of contact birds prior to
the experiment and the probability of infection.
Additional file 1 Figure S1 illustrates that the com-
bined analyses enables more precise estimation of the
epidemiological parameters of interest (Table 2). The
figure furthermore shows that there are no large differ-
ences between the means of the latent period of inocu-
lated versus contact birds.
The result of the logistic regression of infection out-
come as a function of HI titer prior to the experiment
was largely inconclusive, as only 4 out of 62 contact
birds in trials with a successfully infected inoculated
bird had not been infected, and as HI titers prior to the
experiment were low and showed little variation (four
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Figure 4 Overview of the analyses of Experiment 3 (vaccination
at day 10, challenge at day 28). See Figure 1 for details.
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birds had a HI titer of 4, the remainder had HI titers of
0-2). The analysis indicated that the predicted probabil-
ity of infection decreased from 95% if the initial HI titer
was 0, to 93% if the initial HI titer was 2. However, the
associated confidence intervals are wide, and the para-
meter determining the slope is not significantly different
from 0 (p = 0.63). HI titers of all birds are given in
Additional file 2 Table S1.
Discussion
The aim of this study was to quantify the effect of a sin-
gle vaccination of broilers against a HPAI H5N1 on
virus transmission, and to which extent virus could
spread among broilers and DOC. Vaccination with an
inactivated homologous strain did not reduce transmis-
sion of H5N1 virus significantly. In both vaccine experi-
ments, in which birds were vaccinated when they were
either one or ten days old, the reproduction number
was above one indicating that virus could still spread
extensively. Moreover vaccination did not prevent the
occurrence of clinical signs, although it seemed to
reduce mortality slightly. This implies that unnoticed
virus spread is unlikely, even in a vaccinated flock,
which is often feared by farmers and policy makers as
mentioned before [14,15,33].
Transmission among day-old chickens, which still had
MDA, tended to be reduced compared to chickens of
four weeks of age without MDA, as fewer contact birds
became infected, but the reproduction number was not
significantly below one. Of course the real control
group, MDA-free DOC, was lacking, as this was not our
research question. In various trials, the clinical signs
seemed to be less severe, suggesting that these DOCs
may pose a risk in the spread of the infection as they
may spread the virus unnoticed. These findings indicate
that broilers, including DOC, could play a role in the
epidemiology of AI, as virus could spread extensively. It
cannot be determined from these experiments, however,
to which extent this may occur in the field, as this also
depends on the number of virus incursions, and the
subsequent implemented control measures.
Vaccination only induced very low titers of HI antibo-
dies in few birds and a single vaccination was not effec-
tive in reducing transmission. The most likely
explanation for the reduced efficacy in comparison to
layers was the presence of maternally derived antibodies
at time of vaccination. MDA in general persist in broi-
lers for approximately 14-21 days after hatch [34], and
for AI it has been demonstrated that MDA titers were
low at 7 days after hatching [35]. It has been demon-
strated for other viral infections that MDA may interfere
with an effective immune response [36,37], like for
example for Newcastle disease [38] and infectious bron-
chitis [39]. Whether there was interference between
MDA and vaccination could not be demonstrated in
this study, as no group of broilers without MDA was
included, because this type of broilers is not present in
endemically infected areas in which broiler breeders are
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Figure 5 Overview of the analyses of Experiment 4 (no
vaccination, challenge at day 1). See Figure 1 for details.
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vaccinated regularly, and because it was not the research
question of this study.
A study on AI vaccination in MDA-positive broilers
[35] demonstrated that HI titers remained high until
five weeks post vaccination, indicating that a decrease in
immunity was not to be expected within the interval
vaccination-challenge applied in our trials. Studies have
also shown that HI levels after a single vaccination in
birds with MDA reached a peak at six weeks post vacci-
nation [15,35], suggesting our interval being too short.
We challenged at 28 days of age, however, as this was
assumed to be a reasonable interval for field conditions
and also considering the duration of the experiments
and applied before [40].
Another explanation for the failing immune response
is that broilers have an immature immune system, as
broilers have been bred for growth characteristic, which
may have an effect on both the humoral and cellular
immune responses [41]. Although the birds in our
experiments were not protected, other studies have
shown that AI vaccination of broilers at 10 days of age
gave satisfactory antibody titers and clinical protection
after challenge [35,42,43]. A possible explanation for the
difference between their observations and ours is the
use of different vaccines or adjuvantia.
In our experiment, some birds did survive the infec-
tion, although the HI titers at challenge were below 32.
In the unvaccinated experiments with 4-week-old birds,
for example, all inoculated birds shed virus and showed
clinical sign, but some contact-infected chickens sur-
vived for more than 10 days. This was also observed in
the vaccine experiments and DOC experiment. How-
ever, no association could be found between HI titer at
moment of challenge and protection against contact-
infection and also not between HI titer and infection
after inoculation. This phenomenon has also been
observed in studies on for example H7N7 in turkeys
[44], and on Newcastle disease [45]. In the latter experi-
ment, vaccinated birds with low or undetectable anti-
body titres were protected against disease and mortality,
but infection and transmission still occurred. One expla-
nation for surviving of contact birds is that these birds
had become infected with a low virus dose. As the birds
were housed in pairs, the exposure dose could have
been low, as some of the inoculated chickens in this
experiment died before having shed a large amount of
virus. However, Spekreijse et al. [46] showed that the
case fatality rate of chickens did not differ between dose
groups, and in their experiments all birds that were
infected died eventually. Another explanation is that
other immune responses than antibodies were induced,
such as a cellular immunity, although it is generally
assumed that inactivated vaccines usually induce a B cell
response only [47]. Another possibility is that the low
HI titers may have been sufficiently high to induce
some protection.
Of course extrapolation of results from experiments
to the field should always be done with caution. Never-
theless, our results indicate that vaccination is not
effective in broilers, as early vaccination does not
induce a good immune response and if vaccination is
applied later, the birds may be protected the moment
they are slaughtered. Henning et al. [48] demonstrated
that the risk of infection was higher in flocks vacci-
nated once, in comparison to two vaccinations, also
suggesting that vaccination of broilers will not be very
effective, but it does not seem to be feasible vaccinat-
ing broilers even twice. Although discrepancies
between laboratory and field results have been
observed more often [49], the efficacy of vaccination is
usually higher under experimental conditions than
under field conditions. Therefore, a proper vaccination
scheme with killed vaccines seems useless, although
use of other types of vaccines [17,33] could be more
successful. Adequate biosecurity measures should
therefore be implemented in endemically infected
countries to control AI [2,14,15,17,50].
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